Showing 20 of 120 recruiting trials for “non-rare-in-europe-non-small-cell-lung-cancer”
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.
👨⚕️ Oscar G Arrieta, M.D., M.Sc., Instituto Nacional de Cancerologia de Mexico📍 1 site📅 Started Feb 2023View details ↗
RecruitingNCT04777175 ↗
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
👨⚕️ Taofeek K Owonikoko, MD/PhD, University of Maryland, Marlene & Steward Greenebaum Comprehensive Cancer Center 22 S Greene St, Baltimore, MD 21201📍 8 sites📅 Started Nov 2022View details ↗
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
👨⚕️ Corinne Faivre-Finn, MD, The Christie NHS Foundation Trust📍 41 sites📅 Started Oct 2022View details ↗
RecruitingNCT04909073 ↗
Observational Study of Afatinib 30 mg Daily
Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer with Leptomeningeal Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →